Application of the ICF -CY in physiotherapy with a specific method in a patient with hypotonia and delayed motor development secondary to Bainbridge-Ropers Syndrome
DOI:
https://doi.org/10.28957/rcmfr.382Keywords:
Outcome of treatment, electrical stimulation therapy, physiotherapy modalities, International Classification of Functioning, Disability, HealthAbstract
Introduction. Bainbridge-Ropers syndrome (BRPS; OMIM 615485) is a rare genetic disorder, first identified in 2013, that causes developmental delay, hypotonia, intellectual disability, and problems with growth, eating, and language acquisition. In managing this disorder, it is vital to consider the International Classification of Functioning, Disability, and Health Version for Childhood and Adolescence (CIF-IA) as a tool to measure the evolution of physiotherapeutic intervention over time.
Case presentation. A female patient from Medellín (Colombia), without a history of high-risk childbirth, presented hypotonia and delayed motor development secondary to Bainbridge-Ropers syndrome. The CIF-IA was applied to the child under the selected 34 criteria for evaluation and monitoring of such evaluation. After 11 months of treatment with the Vojta method and electrotherapy, favorable evolution was observed: She achieved gait, language acquisition, interaction with her family, play with her sister, schooling, and sphincter control.
Conclusions. The longitudinal analysis based on the time of the patient’s treatment and from the CIF-IA showed changes in the 34 qualifiers selected throughout the intervention with Vojta therapy in combination with electrotherapy. Intervention with the Vojta method did not require prolonged treatment (11 months) or high consultation attendance to achieve good results.
References
Kuechler A, Czeschik JC, Graf E, Grasshoff U, Hüffmeier TB, Busa T, et al. Bainbridge–Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition. Eur J Hum Genet. 2016;25(2):183-91. Disponible en: https://doi.org/10.1038/ejhg.2016.165.
Bainbridge N, Hu H, Muzny DM, Musante L, Lupski JR, Graham BH, et al. De novo truncating mutations in ASXL3 are associated with a novel clinical phenotype with similarities to Bohring-Opitz syndrome. Genome Med. 2013;5(2):11. Disponible en: https://doi.org/10.1186/gm415.
Russell B, Graham JM Jr. Expanding our knowledge of conditions associated with the ASXL gene family. Genome Med. 2013;5(16). Disponible en: https://doi.org/10.1186/gm420.
Dad R, Walker S, Scherer SW, Hassan MJ, Kang SY, Minassian BA. Hyperventilation-athetosis in ASXL3 deficiency (Bainbridge-Ropers) syndrome. Neurol Genet. 2017;3(5):e189. Disponible en: https://doi.org/10.1212/NXG.0000000000000189.
Ministerio de Sanidad y Política Social & Organización Mundial de la Salud (OMS). Clasificación Internacional del Funcionamiento, de la Discapacidad y de la Salud: Versión para la infancia y adolescencia: CIF-IA. Ginebra: OMS; 2001.
Myers KA, White SM, Mohammed S, Metcalfe KA, Fry EA, Wraige E, et al. Childhood-onset generalized epilepsy in Bainbridge-Ropers syndrome. Epilepsy Res. 2018;140:166-70. Disponible en: https://doi.org/10.1016/j.eplepsyres.2018.01.014.
Zhang R, He XH, Lin HY, Yang XH. Bainbridge-Ropers syndrome with ASXL3 gene variation in a child and literature review. Zhonghua Er Ke Za Zhi. 2018;56(2):138-41. Disponible en: https://doi.org/10.3760/cma.j.issn.0578-1310.2018.02.013.
Gaona VA. Síndrome hipotónico del lactante [XXXVII Reunión Anual de la Sociedad Española de Neurología Pediátrica. XXI Congreso de la Academia Iberoamericana de Neurología Pediátrica]. Revista de neurología. 2013;57(Suppl 1):S23-S35. Disponible en: https://doi.org/10.33588/rn.57S01.2013235.
Castro-Galeano SM. Abordaje fisioterapéutico en infante con hipotonía congénita por hiperglicinemia no cetósica. Rev Col Med Fís Rehab. 2018;28(1):75-84. Disponible en: https://doi.org/10.28957/rcmfr.v28n1a8.
Vojta V, Schweizer E. El descubrimiento de la motricidad ideal. Madrid: Ediciones Morata; 2011. 11. Sanz-Esteban I, Calvo-Lobo C, Ríos-Lago M, Álvarez-Linera J, Muñoz-García D, Rodríguez-Sanz D. Mapping the human brain during a specific Vojta’s tactile input: the ipsilateral putamen’s role. Medicine (Baltimore). 2018;97(13):e0253. Disponible en: https://doi.org/10.1097/MD.0000000000010253.
Juarez-Albuixech ML, Redondo-Gonzalez O, Tello I, Collado-Vazquez S, Jimenez-Antona C. Vojta Therapy versus transcutaneous electrical nerve stimulation for lumbosciatica syndrome: A quasi-experimental pilot study. J Bodyw Mov Ther. 2020;24(1):39-46. Disponible en: https://doi.org/10.1016/j.jbmt.2019.05.015.
Jung MW, Landenberger M, Jung T, Lindenthal T, Philippi H. Vojta therapy and neurodevelopmental treatment in children with infantile postural asymmetry: a randomised controlled trial. J Phys Ther Sci. 2017;29(2):301-6. Disponible en: https://doi.org/10.1589/jpts.29.301.
Gajewska E, Huber J, Kulczyk A, Lipiec J, Sobieska M. An attempt to explain the Vojta therapy mechanism of action using the surface polyelectromyography in healthy subjects: A pilot study. J Bodyw Mov Ther. 2018;22(2):287-92. Disponible en: https://doi.org/10.1016/j.jbmt.2017.07.002.
Colombia. Ministerio de Salud. Resolución 8430 de 1993 (octubre 4): Por la cual se establecen las normas científicas, técnicas y administrativas para la investigación en salud. Bogotá D.C.; octubre 4 de 1993.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Revista Colombiana de Medicina Física y Rehabilitación
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
